Estimaciones de analistas de Wall Street para Pliant Therapeutics, Inc. (PLRX): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Ratios de valoración
| Precio / Valor contable | 0.48 |
| EV / EBITDA | -0.86 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | $57.1M | $41.8M | $7.6M | $9.7M | $1.6M | 0 | 0 |
| Coste de Ventas | 0 | $666000 | 0 | 0 | 0 | 0 | 0 | 0 | $1.7M |
| Beneficio Bruto | 0 | -$666000 | $57.1M | $41.8M | $7.6M | $9.7M | $1.6M | 0 | -$1.7M |
| I+D | $14.5M | $24.4M | $47.4M | $66.2M | $77.5M | $96.9M | $127.8M | $169.3M | $109.2M |
| Generales y Administrativos | $3.8M | $6.5M | $10.9M | $17.3M | $27.6M | $39.9M | $57.9M | $59.1M | $47.2M |
| Gastos Operativos | $18.3M | $30.9M | $58.3M | $83.5M | $105.1M | $136.9M | $185.7M | $228.4M | $148.4M |
| Beneficio Operativo | -$18.3M | -$30.9M | -$1.2M | -$41.6M | -$97.5M | -$127.2M | -$184.1M | -$228.4M | -$150.1M |
| EBITDA | -$18.1M | -$30.2M | -$118000 | -$40.3M | -$95.7M | -$118.8M | -$158.2M | -$205.2M | -$145.1M |
| Gastos por Intereses | 0 | 0 | $216000 | $366000 | 0 | $791000 | $1.3M | $3.0M | $2.6M |
| Beneficio Antes de Impuestos | -$18.3M | -$30.3M | -$631000 | -$41.5M | -$97.3M | -$123.3M | -$161.3M | -$210.3M | -$149.3M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$20.6M | -$30.3M | -$631000 | -$41.5M | -$97.3M | -$123.3M | -$161.3M | -$210.3M | -$149.3M |
| BPA | $-25.67 | $-1.83 | $-0.19 | $-1.17 | $-2.71 | $-2.94 | $-2.75 | $-3.47 | $-2.43 |
| BPA Diluido | $-25.67 | $-1.83 | $-0.19 | $-1.17 | $-2.71 | $-2.94 | $-2.75 | $-3.47 | $-2.43 |
| Acciones en Circulación (Diluidas) | $803497 | $16.5M | $35.6M | $35.6M | $35.8M | $42.0M | $58.7M | $60.5M | $61.4M |
Precio
| Precio | $1.07 |
| Capitalización | $66M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ADVM · ARTV · CLNN · COYA · GUTS · MGNX · OVID
Explorar sector: Healthcare · Biotechnology
Más secciones de PLRX: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones